Amphastar Pharmaceuticals, Inc.
AMPH
$23.00
$0.070.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.69% | -44.06% | -38.51% | -29.22% | -19.10% |
| Total Depreciation and Amortization | 6.88% | 10.33% | 10.48% | 9.85% | 9.15% |
| Total Amortization of Deferred Charges | 10.25% | -28.12% | -44.38% | -60.92% | -75.84% |
| Total Other Non-Cash Items | 348.23% | 348.74% | 1,009.45% | -60.40% | 38.45% |
| Change in Net Operating Assets | 64.80% | -41.49% | -353.50% | 2.66% | -64.39% |
| Cash from Operations | 15.63% | -12.58% | -26.84% | -26.87% | -24.90% |
| Capital Expenditure | 33.18% | 21.55% | 15.01% | -2.49% | -37.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.11% | -251.10% | -178.58% | 74.55% | 34.70% |
| Cash from Investing | 13.83% | 24.78% | 43.70% | 76.37% | 68.02% |
| Total Debt Issued | -97.79% | -71.40% | -66.28% | -20.30% | -94.23% |
| Total Debt Repaid | -203.90% | 97.39% | 97.30% | 99.60% | 99.91% |
| Issuance of Common Stock | 685.02% | -- | -- | -75.48% | -91.31% |
| Repurchase of Common Stock | 16.98% | -1.58% | 16.30% | -81.25% | -72.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.03% | 73.12% | 15.81% | 50.56% | 88.91% |
| Cash from Financing | 4.84% | -1.53% | 16.71% | 12.00% | -765.33% |
| Foreign Exchange rate Adjustments | -192.47% | -284.00% | 210.53% | 149.88% | 147.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,961.40% | 35.52% | 153.90% | 130.69% | -105.00% |